NCT05984849 Playing Game to Learn About Children's Vaccine Project
| NCT ID | NCT05984849 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Michigan State University |
| Condition | HPV |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2025-10-27 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2025-10-27 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This proposed study aims to conduct timely research that promotes vaccine confidence and vaccination of one strongly recommended vaccine with suboptimal uptake rates: Human papillomavirus (HPV) in vulnerable and underserved youth aged 11-14.
Eligibility Criteria
Inclusion Criteria: * Child sample: (1) 11-14 years old, (2) speaks and reads English, (3) has never received any doses of the HPV vaccine, (4) is not currently enrolled in another project that involves HPV-related education, and (5) agrees and provides assent to participate in research activities. * Parent sample: (1) parent or legal guardian of the participating child, (2) speak and read English, (3) own a smartphone, (4) agree to receive email and text messages, (5) is not currently enrolled in another project that involves HPV-related education, and (6) agree and provide consent to participate in research activities. Exclusion Criteria: Individuals who do not meet inclusion criteria or refuse to provide consent/assent.
Contact & Investigator
ANGELA C CHEN, PhD
PRINCIPAL INVESTIGATOR
Michigan State University
Frequently Asked Questions
Who can join the NCT05984849 clinical trial?
This trial is open to participants of all sexes, aged 11 Years or older, up to 14 Years, studying HPV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05984849 currently recruiting?
Yes, NCT05984849 is actively recruiting participants. Contact the research team at VaccineHealthGame@msu.edu for enrollment information.
Where is the NCT05984849 trial being conducted?
This trial is being conducted at Chandler, United States.
Who is sponsoring the NCT05984849 clinical trial?
NCT05984849 is sponsored by Michigan State University. The principal investigator is ANGELA C CHEN, PhD at Michigan State University. The trial plans to enroll 180 participants.